BioCentury
ARTICLE | Company News

Bioceros, Epirus deal

September 14, 2015 7:00 AM UTC

Johnson & Johnson (NYSE:JNJ, New Brunswick, N.J.) markets Simponi and Stelara to treat autoimmune diseases. Epirus would not disclose when the company plans to begin clinical testing for the acquired...